Cipla Q4 Results: Profit jumps 30% YoY; declares dividend of ₹16

Cipla Q4 Results: Pharmaceuticals company Cipla on Tuesday, May 13, reported a 30.12 per cent year-on-year (YoY) rise in its Q4FY25 consolidated net profit to ₹1,221.84 crore compared to ₹939.04 crore in the corresponding quarter of the previous financial year.

Revenue from sales rose 8.5 per cent YoY to ₹6,597.72 crore from ₹6,082.37 crore in Q4FY24. The pharmaceuticals segment clocked a revenue of ₹6,503.63 crore in Q4FY25, up 8.5 per cent against ₹5,996.38 crore in Q4FY24. Revenue from new ventures increased 35.44 per cent YoY to ₹288.48 crore from ₹212.99 crore in the same quarter of FY24.

EBITDA for the quarter jumped 17 per cent YoY to ₹1,538 crore, while EBITDA margin increased 150 bps YoY to 22.8 per cent.

Meanwhile, the company announced a final dividend of ₹13 per equity share for FY25 and a special dividend of ₹3 per equity share on the occasion of completing 90 years of the company, taking the total dividend to ₹16 per equity share of face value of ₹2 each.

(This is a developing story. Please check back for fresh updates.)

Catch all the Business News , Market News , Breaking News Events and Latest News Updates on Live Mint. Download The Mint News App to get Daily Market Updates.

Download the Mint app and read premium stories